🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, double-blind, placebo-controlled, multi-center,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT03532958
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
Study aims at evaluating the therapeutic efficacy and safety of low-dose IL...
Status
Active Not Recruiting
Location
GHU Saint Anne
Start Date
2022-10-11
Trial ID
NCT05468073
MIROCALS is a phase II study of ld-IL-2 as a therapeutic agent for ALS. A r...
Status
Completed
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2017-06-19
Trial ID
NCT03039673
Treatments Being Tested
The purpose of the study is to evaluate an investigational medication to tr...
Status
Completed
Location
Medical Research Associates
Start Date
2001-09
Trial ID
NCT00028288
Treatments Being Tested
Neuroinflammation is a significant component of Alzheimer disease (AD). Our...
Status
Unknown
Location
Houston Methodist Research Institute
Start Date
2022-01-01
Trial ID
NCT06096090
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
In patients who are receiving intravenous high dose Interleukin-2, patients...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-04
Trial ID
NCT00001812
Treatments Being Tested
The study will compare the immune response in CeD patients to wheat and bar...
Status
Completed
Location
Clinical Center for Celiac Disease and Autoimmunity
Start Date
2024-01-01
Trial ID
NCT06151782
The preceding IVORY trial (NCT04241601) has completed. As atherosclerosis a...
Status
Recruiting
Location
Addenbrooke's Hospital
Start Date
2024-06-01
Trial ID
NCT06427694
Treatments Being Tested